Cath Lab

The cardiac catheterization laboratory is used for diagnostic angiograms and percutaneous coronary interventions (PCI). Cath labs have also seen expanding use in recent years for transcatheter structural heart procedures. Some hospitals also share these labs with other subspecialties for catheter-based procedures in electrophysiology (EP), interventional radiology, peripheral artery disease (PAD), carotid and neuro interventional procedures and vascular surgery.

Thumbnail

Survival rates similar when treating secondary MR with TEER or surgery

Surgical mitral valve repair, however, was also associated with multiple benefits.

Amulet vs. Watchman: LAA occluder devices compared in new head-to-head trial

The Amulet's implantation success rate and LAA closure rate were both higher than the first-generation Watchman device, researchers reported.

Thumbnail

LAAO outcomes significantly worse among women

Researchers tracked data from more than 49,000 patients who underwent LAAO from January 2016 to June 2019.

Abbott’s LAA closure solution for AFib patients gains FDA approval

The device has already been approved in other parts of the world, including Europe. 

Thumbnail

TMVR outcomes suffer when patients have heart failure and diabetes—but benefits remain

Overall, the authors emphasized, TMVR helped heart failure patients with and without diabetes.

Next-day discharge after TMVR is on the rise

By 2018, nearly half of all TMVR patients were going home the very next day. Outcomes for these patients have been consistently positive. 

Thumbnail

TEER shows potential to boost outcomes for cardiogenic shock patients

Cardiogenic shock has been linked to a heightened risk of morbidity and mortality. TEER, it seems, may be able to help provide patients with some relief. 

Thumbnail

How diabetes impacts TEER outcomes

The new analysis, published in JACC: Heart Failure, focused on patient data from the renowned COAPT trial.